Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12991-6. doi: 10.1073/pnas.0805802105. Epub 2008 Aug 26.

2.

Human embryonic stem cells: potential tool for achieving immunotolerance?

Menendez P, Bueno C, Wang L, Bhatia M.

Stem Cell Rev. 2005;1(2):151-8. Review.

PMID:
17142850
3.

Immunogenicity of human embryonic stem cells.

Grinnemo KH, Sylvén C, Hovatta O, Dellgren G, Corbascio M.

Cell Tissue Res. 2008 Jan;331(1):67-78. Epub 2007 Sep 11. Review.

PMID:
17846795
4.

Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.

Bumgardner GL, Orosz CG.

Immunol Rev. 2000 Apr;174:260-79. Review.

PMID:
10807522
5.

The role of CD8+ T cells during allograft rejection.

Bueno V, Pestana JO.

Braz J Med Biol Res. 2002 Nov;35(11):1247-58. Review.

6.

CNS immunological modulation of neural graft rejection and survival.

Borlongan CV, Stahl CE, Cameron DF, Saporta S, Freeman TB, Cahill DW, Sanberg PR.

Neurol Res. 1996 Aug;18(4):297-304. Review.

PMID:
8875445
7.

Pluripotent stem cells: immune to the immune system?

Pearl JI, Kean LS, Davis MM, Wu JC.

Sci Transl Med. 2012 Dec 12;4(164):164ps25. doi: 10.1126/scitranslmed.3005090. Review.

8.

Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.

Lui KO, Waldmann H, Fairchild PJ.

Curr Stem Cell Res Ther. 2009 Jan;4(1):70-80. Review.

PMID:
19149632
9.

Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies.

Boyd AS, Fairchild PJ.

Expert Rev Clin Immunol. 2010 May;6(3):435-48. doi: 10.1586/eci.10.20. Review.

PMID:
20441429
10.

Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts.

Don CW, Murry CE.

J Cell Mol Med. 2013 Nov;17(11):1355-62. doi: 10.1111/jcmm.12147. Epub 2013 Oct 9. Review.

11.

Immune problems in central nervous system cell therapy.

Barker RA, Widner H.

NeuroRx. 2004 Oct;1(4):472-81. Review.

12.

Paradoxical aspects of rapamycin immunobiology in transplantation.

Ferrer IR, Araki K, Ford ML.

Am J Transplant. 2011 Apr;11(4):654-9. doi: 10.1111/j.1600-6143.2011.03473.x. Review.

13.

Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease.

Leavitt AD, Hamlett I.

Clin Transl Sci. 2011 Aug;4(4):298-305. doi: 10.1111/j.1752-8062.2011.00281.x. Review.

14.

Immunological considerations for cell therapy using human embryonic stem cell derivatives.

Drukker M.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2008 Dec 16.

15.

Cell replacement therapy and the evasion of destructive immunity.

Fairchild PJ, Robertson NJ, Cartland S, Nolan KF, Waldmann H.

Stem Cell Rev. 2005;1(2):159-67. Review.

PMID:
17142851

Supplemental Content

Support Center